Continuous glucose monitoring system: an attractive support tool in diabetes education
DOI:
https://doi.org/10.1002/edn.13Keywords:
continuous glucose monitoring, diabetes education, patient involvementAbstract
AbstractThe study was designed to determine the usefulness of the CGMS (continuous glucose monitoring system) as a support tool in type 1 diabetes education. The CGMS is a sensor system that measures interstitial glucose levels every five minutes for three or more days, by means of a microelectrode inserted in the subcutaneous tissue.
People with type 1 diabetes (n=52), who actively participated in diabetes selfmanagement programmes, were monitored with CGMS during three to five days. Patients were selected for CGMS when unsatisfied with the glycaemic results achieved, given the effort made. Ten patients used CSII, 14 used insulin glargine plus rapid acting insulin analogue and 28 used NPH insulin plus short acting insulin. All patients used blood glucose self-monitoring, with a mean of 6.5±1.4 glucose readings per day. The CGMS register was evaluated with the patient. Mean capillary glucose during the 15 days prior to CGMS, mean capillary glucose during CGMS and mean capillary glucose during the 15 days after CGMS are compared.
Discussion of the record with the patient frequently allowed detection of inappropriate solving attitudes. Mean capillary glucose dropped from 155±20mg/dL (8.60±1.11mmol/L) prior to CGMS to 143±20mg/dL (7.94±1.11mmol/L) after CGMS (p=0.000). The effectiveness of CGMS (number of patients in whom mean glucose improved) rose from 66.7% in 2001 to 70.6% in 2002, 78.9% in 2003 and 88.8% in 2004.
When the patient is involved in the analysis of glucose fluctuations, CGMS is a useful tool in diabetes education that will help achieve attitude changes because of the evidence depicted by the continuous glucose record. Experience in the use of this tool by the professional will improve its effectiveness.
Downloads
References
The Diabetes Control and Complications Trial Research Group. The effect of intensive treat-ment of diabetes on the develop-ment and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1991; 90: 450–459.
American Diabetes Association. Tests of glycemia in diabetes. Diabetes Care 2004; 26 (Suppl 1): S91—S93.
Bode BW, Gross TM, Thorton KR, et aL. Continuous glucose monitoring facilitates sustainable improvements in glycemic control. Diabetes 2000; 49 (Suppl 1): A393.
Kaufman FR, Gibson LC, Halvorson M, et aL A pilot study of the continu-ous glucose monitoring system: clin-ical decisions and glycemic control after its use in pediatric type 1 dia-betic patients. Diabetes Care 2001; 24: 2030–2034.
Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pedi-atric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003; 111: 933–938.
Schaepelynck-Belicar P, Vague P, Simonin G, et al. Improved meta-bolic control in diabetic adolescents using the continuous glucose moni-toring system (CGMS). Diabetes Metab 2003; 29: 608–612.
Cameron FJ, Ambler GR. Does con-tinuous glucose monitoring have clinical utility in contemporary man-agement of diabetes?. J Paediatr Child Health 2004; 40: 79–84.
Chico A, Vidal-Rios P, SubirA. M, et aL The continuous glucose monitoring system is useful for detecting unrec-ognized hypoglycemias in patients with type 1 diabetes but is not better than frequent capillary glucose measurements for improving meta-bolic control. Diabetes Care 2003; 26: 1153–1157.
Lopez-Siguero JP, Garcia Arias MJ, del Pino de la Fuente A, et aL Monitorización continua de glucosa en la diabetes tipo1. Anales de Pediatria 2003; 58: 217–221.
Kubiak T, Hermanns N, Schreckling HJ, et aL Assessment of hypogly-caemia awareness using continuous glucose monitoring. Diabetic Med 2004; 21: 487–490.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2005 Copyright © 2005 FEND
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.